A pharmacy buying goserelin must match the depot interval, delivery device, approved indication, storage route and Ghanaian import status before comparing quotations. By the end, you will have a practical way to reject mismatched stock and identify an option that fits patient schedules, inventory controls and regulatory requirements.
Key takeaways
- Confirm the protocol specifies goserelin 10.8 mg every 12 weeks.
- Check the implant pack, batch number, expiry date and product documents.
- Verify Ghana FDA requirements before importing or distributing in Accra.
- Compare landed cost, shelf life, lead time and supplier documentation—not unit price alone.
When does the 10.8 mg depot fit the treatment protocol?
The 10.8 mg depot fits when the prescriber’s protocol calls for goserelin 10.8 mg as a subcutaneous implant every 12 weeks. It is not automatically suitable because it reduces injection visits: the indication, treatment duration, patient factors and approved product label must match.
| Option | Schedule and form | Decision point |
|---|---|---|
| Zoladex 10.8 mg | One prefilled subcutaneous implant every 12 weeks | Use when the protocol specifies the long-acting goserelin depot |
| Goserelin 3.6 mg | A shorter-interval goserelin depot, usually administered every 28 days | Choose when monthly review or the 3.6 mg schedule is prescribed |
| Another hormonal therapy | Different active ingredient, depot interval and device | Substitute only after the prescriber confirms the treatment protocol and local authorization |
For prostate cancer, goserelin can cause an initial testosterone flare. The prescriber may require antiandrogen cover at treatment initiation; the implant should not be presented as producing immediate androgen suppression.
Goserelin also appears in protocols for hormone-sensitive breast cancer or endometriosis, but an indication for one condition does not make the product suitable for every patient.
A quotation from a zoladex 10 point 8 mg exporter must identify the product as the 10.8 mg prefilled implant, not a liquid goserelin injection. Compare the active ingredient, strength, 12-week depot interval, subcutaneous route, delivery device, approved indication and interchangeability status before treating a generic goserelin product or triptorelin depot as an alternative.
What exactly should arrive in a Zoladex 10.8 mg pack?
A genuine Zoladex 10.8 mg pack should identify goserelin acetate equivalent to 10.8 mg of goserelin, supplied as a biodegradable implant in a prefilled delivery device for subcutaneous administration. The product information should state the 12-week depot interval and the approved indication for the market where you will use it.
It is not a conventional liquid vial.
Compare the pack identity against the quotation, outer carton and primary packaging:
| Option | What should be shown | What it means |
|---|---|---|
| Zoladex 10.8 mg | Zoladex name, goserelin 10.8 mg equivalent, prefilled implant, subcutaneous route, 12-week depot | Branded long-acting goserelin presentation |
| Goserelin 3.6 mg | Goserelin 3.6 mg equivalent and a shorter depot interval, usually 28 days | Same active ingredient, different strength and replenishment schedule |
| Generic goserelin 10.8 mg | Goserelin name, manufacturer, 10.8 mg equivalent, device and approved interval | Possible alternative, not the Zoladex brand |
| Triptorelin | Triptorelin as the active ingredient, with its own strength, device and dosing interval | Different medicine; do not treat it as an automatic substitute |
Ask a Zoladex injection supplier to confirm whether the quotation is for the originator brand or a registered generic. Request photographs or samples of the carton and primary pack, plus the manufacturing site, approved market, batch-release documents and remaining shelf life on arrival.
A listing that says only “goserelin injection” or “anti-cancer medicine” does not establish the strength, implant device, interval or Ghana authorization. Reject the comparison until those fields match your prescription and purchasing specification.
How should the pharmacy receive, store and inspect the implant?
Keep the unopened pack below 25°C, in its original carton, away from direct sunlight and moisture. Do not freeze it. During transport, require a sealed shipper that protects the prefilled applicator from crushing, puncture and temperature excursions; review the temperature record when the shipment includes a data logger.
A quotation from a goserelin acetate injection exporter in Accra is not enough to confirm the correct presentation. Match the delivered pack against the purchase order and approved product information:
- Confirm goserelin acetate equivalent to 10.8 mg of goserelin, a 12-week biodegradable implant, subcutaneous route and prefilled delivery system.
- Check that the outer carton, sterile inner pouch and applicator are present and sealed.
- Reject or quarantine any pack with a torn pouch, broken seal, wet or crushed carton, bent applicator, exposed needle or suspected heat damage.
- Read the batch or lot number and expiry date on the carton and device packaging; they must be clear and identical.
- Record the quantity received, lot number, expiry, transport temperature, delivery date and supplier documents before stock entry.
Do not remove the implant from its sterile pouch or transfer it into another container. Quarantine unclear, damaged or temperature-exposed stock, then obtain a written disposition from the manufacturer or supplier before administration. Keep the lot record linked to the patient and administration date so a recall or safety investigation can reach the individual dose.
What must an Accra buyer verify before placing an order?
Before accepting a quotation, confirm the product’s Ghana Food and Drugs Authority registration and the proposed Ghanaian importer’s authorization. A supplier calling itself an anti cancer medicine exporter in accra has not proved that either exists.
Ask for the registration number, registered brand or generic name, approved indication, strength, dosage form, manufacturer and local market-authorisation holder.
Request these records before payment or shipment:
- Ghana FDA product-registration evidence for the exact 10.8 mg presentation, not a 3.6 mg goserelin record.
- The proposed importer’s current Ghana FDA licence and the consignment-specific import permit.
- The exporter’s company registration, manufacturing or wholesale licence, and current GMP certificate.
- The approved product information, including indication, subcutaneous route, depot interval, storage conditions and pack size.
- A Certificate of Pharmaceutical Product where applicable, plus batch-release certificate, certificate of analysis and manufacturing-site details.
- Outer and primary packaging samples showing batch number, expiry date, manufacturer and Ghana-required labelling.
| Quoted identity | Verify | Purchasing consequence |
|---|---|---|
| Zoladex 10.8 mg | Originator registration, manufacturer and authorised distributor | Do not accept a generic substitute under the brand name |
| Goserelin acetate 10.8 mg | Generic registration, device, indication and interchangeability policy | Confirm substitution with the responsible prescriber or authority |
| Unspecified “injection” | Product identity, registration and import permission | Reject until the quotation becomes specific |
If NIBA HEALTHCARE is the quoted supplier, apply this same document check; the phrase zoladex 10 point 8 mg for anti cancer medicine exporter in accra is a search term, not proof of authorization.
Related product
![]() | Goserelin Acetate Injection Zoladex LA 10.8mg Injection is given as an injection under the skin by a qualified medical professional. View product → |
How should purchasing teams compare quotations beyond unit price?
A quotation fits a three-month replenishment plan only when its commercial terms match patient scheduling, not when its unit price is lowest. Request the exact brand or registered generic, 10.8 mg goserelin strength, 12-week depot, pack size and applicator before comparing the fields below.
| Field | What to compare | Three-month fit |
|---|---|---|
| Minimum order quantity | Units per order, case pack and any mixed-case restriction | Reject an MOQ that leaves more implants than your forecast and available expiry buffer can support. |
| Lead time | Order-to-delivery days, dispatch point and documentation delays | Set the reorder date before the next scheduled implant is due; a long lead time needs earlier purchasing. |
| Remaining shelf life | Minimum months remaining on arrival, not only manufacture and expiry dates | Write the minimum into the RFQ so one shipment covers the current cycle without creating short-dated stock. |
| Payment terms | Advance payment, credit period, bank charges and currency | Compare the cash commitment against the three-month purchasing budget, not just the invoice total. |
| Delivery temperature controls | Label storage range, qualified packaging, data logger and excursion-reporting process | Require evidence that the shipment stayed within the product’s specified range; agree who assesses an excursion. |
| Pharmacovigilance support | Named safety contact, adverse-event reporting route, batch traceability and recall assistance | Confirm support before administration, because a delayed safety report can affect every patient receiving that batch. |
Ask for batch-release documents, the storage-excursion policy and a written replacement process. Treat “exporter” status as separate from Ghana Food and Drugs Authority authorization for the proposed product.
Frequently asked questions
When does the Zoladex 10.8 mg depot fit the treatment protocol?
It fits when the prescriber’s protocol specifies goserelin 10.8 mg as a subcutaneous implant every 12 weeks. Confirm the indication, treatment duration, patient factors and approved product label before ordering.
What should arrive in a Zoladex 10.8 mg pack?
Check that the sealed pack contains the goserelin 10.8 mg implant presentation, delivery syringe or applicator, needle components and approved instructions. Match the product name, strength, batch number and expiry date against the shipping documents.
How should a pharmacy receive, store and inspect the implant?
Record the delivery condition, inspect the outer carton and seal, verify the batch and expiry details, and quarantine damaged or discrepant packs. Store the product exactly within the temperature, light and handling limits printed on its approved label.
What must an Accra buyer verify before placing an order?
Confirm the supplier’s authorization, product registration or import requirements with Ghana’s FDA, the product’s approved label, batch documentation, certificate of analysis, expiry period and delivery conditions.
How should purchasing teams compare Zoladex 10.8 mg quotations beyond unit price?
Compare landed cost, minimum order quantity, remaining shelf life, delivery lead time, transport conditions, documentation, payment terms, replacement policy and the supplier’s ability to support batch traceability.
